Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Posttranslational modifications of self-antigens.

Hester A Doyle1, Mark J Mamula

  • 1Section of Rheumatology, Yale University School of Medicine, P.O. Box 208031, New Haven, CT 06520-8031, USA. hester.doyle@yale.edu

Annals of the New York Academy of Sciences
|July 15, 2005
PubMed
Summary

Autoimmune diseases occur when the immune system mistakenly attacks the body. Posttranslational modification of self-antigens creates new targets, bypassing immune tolerance and triggering autoimmune responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut microbiota of dogs with cancer receiving anti-EGFR/HER2 immunization reveals potential biomarkers of patient survival.

bioRxiv : the preprint server for biology·2025
Same author

Natural isoaspartyl protein modification of ZAP70 alters T cell responses in lupus.

Autoimmunity·2023
Same author

A discovery-based proteomics approach identifies protein disulphide isomerase (PDIA1) as a biomarker of β cell stress in type 1 diabetes.

EBioMedicine·2022
Same author

Biomarkers of autoimmunity and beta cell metabolism in type 1 diabetes.

Frontiers in immunology·2022
Same author

Immune cells and their inflammatory mediators modify β cells and cause checkpoint inhibitor-induced diabetes.

JCI insight·2022
Same author

Carbonyl Posttranslational Modification Associated With Early-Onset Type 1 Diabetes Autoimmunity.

Diabetes·2022

Area of Science:

  • Immunology
  • Biochemistry
  • Pathology

Background:

  • The immune system distinguishes self from non-self to prevent autoimmunity.
  • Autoimmune diseases arise when this self-tolerance mechanism fails.
  • Posttranslational modification (PTM) of self-antigens can create novel targets for immune attack.

Purpose of the Study:

  • To review PTMs of self-antigens implicated in autoimmune diseases.
  • To elucidate the mechanisms by which PTMs arise.
  • To explain how these modified antigens break immune tolerance.

Main Methods:

  • Literature review of PTMs in autoimmune diseases.
  • Analysis of biochemical pathways leading to antigen modification.
  • Immunological mechanisms of tolerance breakdown.

Related Experiment Videos

Main Results:

  • Identified several PTMs of self-antigens associated with autoimmune conditions.
  • Described the cellular and molecular processes generating these modified antigens.
  • Highlighted how PTMs can lead to loss of self-tolerance.

Conclusions:

  • PTM of self-antigens is a significant factor in the pathogenesis of autoimmune diseases.
  • Understanding these modifications offers potential therapeutic targets.
  • Further research into PTMs is crucial for managing autoimmunity.